SANJEEV VASUDEVAN to Combined Modality Therapy
This is a "connection" page, showing publications SANJEEV VASUDEVAN has written about Combined Modality Therapy.
Connection Strength
0.398
-
Pediatric-protocol of multimodal therapy is associated with improved survival in AYAs and adults with rhabdomyosarcoma. Surgery. 2018 02; 163(2):324-329.
Score: 0.111
-
Characteristics and outcomes in children with undifferentiated embryonal sarcoma of the liver: A report from the National Cancer Database. Pediatr Blood Cancer. 2017 04; 64(4).
Score: 0.102
-
Management of undifferentiated embryonal sarcoma of the liver: A Pediatric Surgical Oncology Research Collaborative study. Pediatr Blood Cancer. 2024 Jun; 71(6):e30975.
Score: 0.043
-
Congenital spindle cell rhabdomyosarcoma. Pediatr Blood Cancer. 2019 11; 66(11):e27935.
Score: 0.031
-
Pancreatic islet cell tumors in adolescents and young adults. J Pediatr Surg. 2019 Oct; 54(10):2103-2106.
Score: 0.030
-
Pediatric gastric adenocarcinoma: A National Cancer Data Base review. J Pediatr Surg. 2019 May; 54(5):1029-1034.
Score: 0.030
-
Breast Malignancies in Children: Presentation, Management, and Survival. Ann Surg Oncol. 2017 Jun; 24(6):1482-1491.
Score: 0.026
-
Undifferentiated Embryonal Sarcoma of the Liver (UESL): A Single-Center Experience and Review of the Literature. J Pediatr Hematol Oncol. 2016 05; 38(4):261-8.
Score: 0.025